Mr. Ross will focus on the UK, Ireland and Scandinavia and Mr. Thomas will handle Central and Eastern Europe with an emphasis on expanding business from Germany and Eastern Europe. Along with Nicholas Micheaud, responsible for Southwestern Europe, Mr. Ross and Mr. Thomas report to Jeremy Drummond, the sales director.
Mr. Thomas brings extensive pharmaceutical manufacturing experience having previously worked for UCB. Mr. Ross has wide-ranging experience in contract research and contract manufacturing having held positions with Patheon, Catalant and Ipsen.
Mr. Thomas said, “I am delighted to take on my new position at Aesica and to play a key role in driving forward our services in the German market, as well as Eastern Europe. Indeed, the fact that we have site facilities geographically situated in Monheim and Zwickau as well as in Italy and the UK, ensures that Aesica is well situated to deliver reliable services to customers from all of Europe.”
David Ross said, “I very much look forward to playing a key regional role in driving new business across the UK, Ireland and Scandinavia. The integrated nature, scale and range of our service offering and our track record of transferring in new technologies stand us out in the highly competitive CDMO market place.”